Every case approached individually — anchored in current international protocols, adapted to what will genuinely work for the person in front of her.
Special interest in Triple-Negative Breast Cancer (TNBC), with advanced targeted therapies alongside neoadjuvant and adjuvant regimens.
Systemic therapy for non-small cell and small cell lung cancers, including targeted therapy and immunotherapy.
Haematological malignancies including lymphomas, leukaemias and multiple myeloma — with high-dose chemotherapy expertise.
Complex cases of cervical, ovarian, uterine and endometrial cancers, in young and older patients alike.
Multidisciplinary management of GU cancers and head & neck cancers, coordinated with surgical and radiation oncology.
Advanced protocols for colorectal, oesophageal and other GI cancers, and germ cell tumours.
Cases are approached individually — every plan built one patient at a time.— Dr. Indoo Ammbulkar
Explainers on specific treatments and diagnostic tools, written for patients and families.
How these two CDK4/6 inhibitors for HR-positive breast cancer differ — evidence, side effects, and cost.
What ctDNA testing detects, where it genuinely helps, and where it still falls short.
Where artificial intelligence genuinely helps in oncology today — and where it doesn't.
What actually matters when choosing a cancer specialist near you.
Dr. Ammbulkar takes an active part in awareness activities for cancer prevention, early detection and genetic testing — because a screening conversation today can change the entire arc of what treatment looks like tomorrow.